1 |
Szotowski, B., Antoniak, S., Goldin-Lang, P., Tran, Q.V., Pels, K., Rosenthal, P., Bogdanov, V.Y., Borchert, H.H., Schultheiss, H.P. and Rauch, U. (2007). Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc. Res., 73, 806-812.
DOI
ScienceOn
|
2 |
Vink, S.R., Schellens, J.H., Beijnen, J.H., Sindermann, H., Engel, J., Dubbelman, R., Moppi, G., Hillebrand, M.J., Bartelink, H. and Verheij, M. (2006). Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours. Radiother. Oncol., 80, 207-213.
DOI
ScienceOn
|
3 |
Wada, T. and Penninger, J.M. (2004). Mitogen-activated protein kinases in apoptosis regulation. Oncogene., 23, 2838-2849.
DOI
ScienceOn
|
4 |
Wang, H.G. and Reed, J.C. (1998). Bc1-2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors., 8, 13-16.
DOI
|
5 |
Wilson, R.E., Taylor, S.L., Atherton, G.T., Johnston, D., Waters, C.M. and Norton, J.D. (1993). Early response gene signaling cascades activated by ionizing radiation in primary human B cells. Oncogene., 8, 3229-3237.
|
6 |
Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
DOI
ScienceOn
|
7 |
Zhang, Y. and Chen, F. (2004). Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). Cancer Res., 64, 1902-1905.
DOI
ScienceOn
|
8 |
Kaminski, J.M., Hanlon, A.L., Joon, D.L., Meistrich, M., Hachem, P. and Pollack, A. (2003). Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. Int. J. Radiat. Oncol. Biol. Phys., 57, 24-28.
|
9 |
Keyse, S.M. and Tyrrell, R.M. (1989). Heme oxygenase is the major 32-kDastress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA, 86, 99-103.
DOI
ScienceOn
|
10 |
Kucharczak, J., Simmons, M.J., Fan, Y. and Gelinas, C. (2003). To be, or not to be: NF-kappaB is the answer role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene., 22, 8961-8982.
DOI
ScienceOn
|
11 |
Rosser, C.J., Reyes, A.O., Vakar-Lopez, F., Levy, L.B., Kuban, D.A., Hoover, D.C., Lee, A.K. and Pisters, L.L. (2003). Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 56, 1-6.
|
12 |
Kuo, C.L., Chi, C.W. and Liu, T.Y. (2004). The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett., 203, 127-137.
DOI
ScienceOn
|
13 |
Kuo, C.L., Chi, C.W. and Liu, T.Y. (2005). Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo., 19, 247-252.
|
14 |
Lau, C.W., Yao, X.Q., Chen, Z.Y., Ko, W.H. and Huang, Y. (2001). Cardiovascular actions of berberine. Cardiovasc. Drug Rev., 3, 234-244.
|
15 |
Rosser, C.J., Tanaka, M., Pisters, L.L., Tanaka, N., Levy, L.B., Hoover, D.C., Grossman, H.B., McDonnell, T.J., Kuban, D.A. and Meyn, R.E. (2004). Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Ther., 11, 273-279.
DOI
ScienceOn
|
16 |
Bohnke, A., Westphal, F., Schmidt, A., El-Awady, R.A. and Dahm-Daphi, J. (2004). Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumor cells. Int. J. Radiat. Biol., 80, 53-63.
DOI
ScienceOn
|
17 |
Bristow, R., Benchimol, S. and Hill, R. (1996). The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother. Oncol., 40, 197-223.
DOI
ScienceOn
|
18 |
Bristow, R., Benchimol, S. and Hill, R. (1996). The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother. Oncol., 40, 197-223.
DOI
ScienceOn
|
19 |
Carson, C.C. (2006). Carcinoma of the prostate: overview of the most common malignancy in men. N. C. Med. J., 67, 122-126.
|
20 |
Colombo, R., Naspro, R., Salonia, A., Montorsi, F., Raber, M., Suardi, N., Sacca, A. and Rigatti, P. (2006). Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J. Urol., 176, 2459-2463.
DOI
ScienceOn
|
21 |
Corbiere, C., Liagre, B., Terro, F. and Beneytout, J.L. (2004). Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res., 14, 188-196.
DOI
ScienceOn
|
22 |
Greenlee, R.T., Murray, T., Bolden, S. and Wingo, P.A. (2000). Cancer statistics. Cancer J. Clinic., 50, 7-33.
DOI
ScienceOn
|
23 |
He, Z.W., Zhao, X.Y., Xu, R.Z. and Wu, D. (2006). Effects of berbamine on growth of leukemia cell line NB4 and its mechanism. Zhejiang Da. Xue. Xue. Bao. Yi. Xue. Ban., 35, 209-214.
|
24 |
Hwang, J.M., Kuo, H.C., Tseng, T.H. and Liu, Y.J. (2006). Berberine induces apoptosis through a mitochondria/caspase pathway in human hepatoma cells. Arch. Toxicol., 2, 62-73.
|
25 |
Bohnke, A., Westphal, F., Schmidt, A., El-Awady, R.A. and Dahm-Daphi, J. (2004). Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumor cells. Int. J. Radiat. Biol., 80, 53-63.
DOI
ScienceOn
|
26 |
Baldwin, A.S. (1996). The NF-kappa B and I kappa B proteins:new discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
DOI
ScienceOn
|
27 |
Bergman, P.J. and Harris, D. (1997). Radioresistance, chemoresistance, and apoptosis resistance. The past, present, and future. Vet. Clin. N. Am-Small., 27, 47-57.
DOI
|
28 |
Blumenstein, M., Hossfeld, D.K. and Duhrsen, U. (1998). Indirect radiation leukemogenesis in DBA/2 mice: increased expression of B2 repeats in FDC-P1 cells transformed by intracisternal Aparticle transposition. Ann. Hematol., 76, 53-60.
DOI
|